Join us
Semaglutide vs Tirzepatide: The Bottom Line he data on semaglutide vs tirzepatide is clear about what these drugs do in populations
Based on dermatological research, recovery generally follows this timeline: Months 1-3: Shedding may continue as hair follicles complete their resting phase Months 3-6: New hair growth usually begins as follicles re-enter the active growth phase Months 6-12: Some people may notice improvement in hair density and thickness Months 12+: Continued improvement is possible, and some people report hair returning close to pre-treatment thickness Recovery can vary based on factors like age, recurrent or new stressors, overall health, nutritional status, and genetic predisposition to hair thinning
Because it activates both, it's often called a "dual agonist." The FDA has described tirzepatide (brand name Zepbound) as the first medication of its kind to activate both of these receptors for weight management, and it was approved for that use in November 2023
This minimizes cumulative temperature exposure and preserves potency for the full duration of the vial
Both compounds require subcutaneous administration for consistent bioavailability
